Mobile Applications to Support Diabetes Self-Management Education: Patient Experiences and Provider Perspectives

J Diabetes Sci Technol. 2023 Sep;17(5):1206-1211. doi: 10.1177/19322968231174037. Epub 2023 May 10.

Abstract

Background: Diabetes self-management education and support (DSMES) is a critical component of diabetes care, but time for it is often limited. Digital tools, such as mobile applications (apps), show promise in extending efforts and supporting self-management education, but have not been fully used. Objectives of this multi-phase study were to (1) evaluate an app designed to support patients with insulin therapy and (2) examine provider perspectives on DSMES apps.

Methods: Phase 1: Thirty-two adult patients with type 2 diabetes new to or having difficulties with insulin therapy were introduced to the BDTM Diabetes Care App. Three-month app use and satisfaction and changes in hemoglobin A1c (HbA1c) and diabetes distress were assessed. Phase 2: Sixty diabetes providers completed a survey about their experiences with and perspectives on DSMES apps.

Results: Phase 1: Patients reported satisfaction with the app, and significant improvements in HbA1c and diabetes distress were observed. Phase 2: Most providers viewed apps as adjuncts to diabetes education. Only 33% had previous app experience; however, 100% would consider recommending apps to their patients. Most would spend 5-15 minutes introducing apps to patients. All respondents agreed that the following DSMES app features-evidence-based educational content, data logging and tracking features, customizable user experience, digital coaching via goal setting or reminders, and ability to share data with providers-are key components to consider.

Conclusions: Findings suggest DSMES apps can play a role in self-management support and provide guidance on factors to consider when introducing digital tools into clinical practice.

Trial registration: Clinicaltrials.gov, #NCT03999268.

Keywords: app; diabetes education; digital technology; insulin; self-management; type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 2* / therapy
  • Glycated Hemoglobin
  • Humans
  • Insulin
  • Insulin, Regular, Human
  • Mobile Applications*
  • Patient Outcome Assessment
  • Self-Management*

Substances

  • Glycated Hemoglobin
  • Insulin, Regular, Human
  • Insulin

Associated data

  • ClinicalTrials.gov/NCT03999268